RVL PHARMACEUTICALS

RVL Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing eyecare and medical aesthetics products. Our first FDA-approved eyecare product provides the foundation of our unwavering commitment to improve patients' lives... RVL Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas. We are currently commercializing Upneeq® (oxymetazoline hydrochloride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelids, in adults. Upneeq is the first non-surgical treatment option approved by the FDA for acquired blepharoptosis.

Also known as: RVL Pharma

Primary location: Bridgewater United States